SPECTRUM PHARMACEUTICALS INC's ticker is SPPI and the CUSIP is 84763A108. A total of 142 filers reported holding SPECTRUM PHARMACEUTICALS INC in Q4 2021. The put-call ratio across all filers is 11.38 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $19,223 | +25.1% | 20,024 | -2.3% | 0.00% | – |
| Q1 2023 | $15,368 | +119.4% | 20,490 | +7.8% | 0.00% | – |
| Q4 2022 | $7,004 | -12.4% | 19,006 | -0.0% | 0.00% | – |
| Q3 2022 | $8,000 | -52.9% | 19,013 | -10.5% | 0.00% | – |
| Q2 2022 | $17,000 | +13.3% | 21,251 | +15.1% | 0.00% | – |
| Q1 2022 | $15,000 | -40.0% | 18,468 | -7.8% | 0.00% | – |
| Q4 2021 | $25,000 | -44.4% | 20,035 | -3.1% | 0.00% | – |
| Q3 2021 | $45,000 | -44.4% | 20,673 | -4.4% | 0.00% | – |
| Q2 2021 | $81,000 | +26.6% | 21,633 | +9.9% | 0.00% | – |
| Q1 2021 | $64,000 | -8.6% | 19,677 | -4.2% | 0.00% | – |
| Q4 2020 | $70,000 | -15.7% | 20,534 | +0.7% | 0.00% | – |
| Q3 2020 | $83,000 | +48.2% | 20,387 | +22.5% | 0.00% | – |
| Q2 2020 | $56,000 | -22.2% | 16,646 | -46.4% | 0.00% | – |
| Q1 2020 | $72,000 | -4.0% | 31,082 | +50.8% | 0.00% | – |
| Q4 2019 | $75,000 | -40.9% | 20,616 | +34.6% | 0.00% | – |
| Q3 2019 | $127,000 | – | 15,322 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ALETHEA CAPITAL MANAGEMENT, LLC | 787,973 | $615,000 | 0.77% |
| CM Management, LLC | 600,000 | $468,000 | 0.50% |
| ARMISTICE CAPITAL, LLC | 17,100,000 | $13,338,000 | 0.23% |
| Sargent Investment Group, LLC | 614,600 | $479,000 | 0.15% |
| Ergoteles LLC | 744,275 | $581,000 | 0.02% |
| Sonora Investment Management Group, LLC | 103,000 | $80,000 | 0.01% |
| CAXTON ASSOCIATES LP | 107,135 | $84,000 | 0.01% |
| MCDONALD PARTNERS LLC | 42,570 | $33,000 | 0.01% |
| Pinz Capital Management, LP | 15,600 | $12,000 | 0.01% |
| D. E. Shaw & Co., Inc. | 8,051,858 | $6,281,000 | 0.01% |